Approval · Notice of Compliance 12987 · 2012
YERVOY: Notice of Compliance 12987
Issued February 1, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12987
- Date
- February 1, 2012
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YERVOY | 02379384 | Marketed |
Medicinal ingredients
- IPILIMUMAB 5 MG per ML